Stem Cell Authority, Ltd. (SCAL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 15, 2026, 4:00 PM EST
Stem Cell Authority Market Cap
Stem Cell Authority has a market cap or net worth of $182.7 million as of January 16, 2026. Its market cap has increased by 5,213.61% in one year.
Market Cap
182.70M
Enterprise Value
n/a
Revenue
3.33M
Ranking
n/a
PE Ratio
2.85
Stock Price
$0.00
Market Cap Chart
Since March 16, 2005, Stem Cell Authority's market cap has increased from 300.25K to 182.70M, an increase of 60,749.29%. That is a compound annual growth rate of 36.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 182.70M | 14,900.00% |
| Dec 8, 2025 | 1.22M | -93.36% |
| Dec 31, 2021 | 18.35M | 90.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 811.81M |
| Glass House Brands | 738.79M |
| Elite Pharmaceuticals | 515.71M |
| Northwest Biotherapeutics | 440.23M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 338.05M |
| Silence Therapeutics | 279.15M |